BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 802081)

  • 41. [Importance of the determination of plasma chorionic somatomammotropin in high-risk pregnancy].
    Marsico S; Carbone M; Volpe A; Baviera G
    Arch Ostet Ginecol; 1975; 80(1-3):10-23. PubMed ID: 829748
    [No Abstract]   [Full Text] [Related]  

  • 42. Progesterone concentrations in the sera of patients with intact and aborted hydatidiform moles.
    Dawood MY
    Am J Obstet Gynecol; 1974 Aug; 119(7):911-8. PubMed ID: 4366792
    [No Abstract]   [Full Text] [Related]  

  • 43. Diagnosis and management of pregnancy by the radioreceptorassay of human chorionic gonadotropin.
    Saxena BB; Landesman R
    Am J Obstet Gynecol; 1978 May; 131(1):97-107. PubMed ID: 347938
    [No Abstract]   [Full Text] [Related]  

  • 44. [Directed observation of patients after abortion of a hydatidiform mole].
    Horálek F; Zenísek L; Fingerová H; Hadam I
    Cesk Gynekol; 1969 Mar; 34(3):164-6. PubMed ID: 5770727
    [No Abstract]   [Full Text] [Related]  

  • 45. [Comparative study of blood prolans in molar syndromes using 3 biological assay technics].
    Corréa P; Linhard J; Sarrat H; Diadhiou F; Cherbonnel GM
    Bull Soc Med Afr Noire Lang Fr; 1972; 17(3):332-43. PubMed ID: 4677033
    [No Abstract]   [Full Text] [Related]  

  • 46. Urinary steroid profile in patients with hydatidiform mole. Report of 3 cases.
    Acevedo HF; Vela BA; Campbell EA; Gilmore J; Strickler HS; Merkow LP; Hayeslip DW; Maydak JJ; Ferraro RJ
    Obstet Gynecol; 1970 Jun; 35(6):857-69. PubMed ID: 5446718
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunological and biological activity of human chorionic gonadotrophin in urine and serum of pregnant women and women with a hydatidiform mole.
    Wide L; Hobson B
    Acta Endocrinol (Copenh); 1967 Jan; 54(1):105-12. PubMed ID: 6071205
    [No Abstract]   [Full Text] [Related]  

  • 48. Urinary pigment-creatinine ratio in normal and molar pregnancy.
    Franklin CA; Galton VA; Ingbar SH
    Obstet Gynecol; 1971 May; 37(5):761-4. PubMed ID: 5091756
    [No Abstract]   [Full Text] [Related]  

  • 49. Hydatidiform mole with coexistent fetus: discussion and review of diagnostic methods.
    Clark PB; Gusdon JP; Burt RL
    Obstet Gynecol; 1970 Apr; 35(4):597-600. PubMed ID: 5438151
    [No Abstract]   [Full Text] [Related]  

  • 50. Estriol determinations in the management of high-risk pregnancies.
    Magendantz HG; Klausner D; Ryan KJ; Yen SS
    Obstet Gynecol; 1968 Nov; 32(5):610-9. PubMed ID: 5742475
    [No Abstract]   [Full Text] [Related]  

  • 51. [Proceedings: Serum HPL concentrations in cases of normal and pathological pregnancy in comparison with other endocrine parameters].
    Bellmann O; Patt V; Leyendecker G; Nocke W
    Arch Gynakol; 1973 Sep; 214(1):443-5. PubMed ID: 4801513
    [No Abstract]   [Full Text] [Related]  

  • 52. [Urinary excretion of estrogens, 5-beta-pregnane-3-alpha, 20-alpha diol, 5-beta-pregnane-3-alpha, 17-alpha, 20-alpha-triol and HCG in cases of normal and pathological pregnancy compared with plasma steroid and HCG levels].
    Hamacher M; Nolden HW; Patt V; Leyendecker G; Nocke W
    Arch Gynakol; 1973 Sep; 214(1):208-11. PubMed ID: 4801429
    [No Abstract]   [Full Text] [Related]  

  • 53. Serum estradiol-17beta and serum human chorionic gonadotropin in patients with hydatidiform moles.
    Dawood MY; Ratnam SS; Teoh ES
    Am J Obstet Gynecol; 1974 Aug; 119(7):904-10. PubMed ID: 4366791
    [No Abstract]   [Full Text] [Related]  

  • 54. [Monitoring of pregnancies by hormone assays, the value of HPL estimations (author's transl)].
    Gitsch E; Janisch H; Spona J
    Wien Klin Wochenschr; 1973 Sep; 85(36):585-8. PubMed ID: 4750614
    [No Abstract]   [Full Text] [Related]  

  • 55. Plasma thyrotrophin levels during pregnancy.
    Genazzani AR; Fioretti P; Lemarchand-Beraud T
    J Obstet Gynaecol Br Commonw; 1971 Feb; 78(2):117-22. PubMed ID: 5558829
    [No Abstract]   [Full Text] [Related]  

  • 56. [Diagnostic value of the determination of serum beta human chorionic gonadotropin in extra-uterine pregnancy].
    Carbasse D; Lahaye C; Villaros AM
    Rev Fr Gynecol Obstet; 1986 Jan; 81(1):1-3. PubMed ID: 3515500
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Monitoring the course of serum beta-HCG in disordered early pregnancies].
    von Rechenberg KN; Haberthür F
    Gynakol Rundsch; 1988; 28(3):129-35. PubMed ID: 2458995
    [No Abstract]   [Full Text] [Related]  

  • 58. [Semiquantitative immunological determinations of chorionic gonadotropins with the gravimun test in normal pregnancy and in threatened abortion].
    Nieder J; Kapitz W
    Zentralbl Gynakol; 1970 Jun; 92(23):721-7. PubMed ID: 5513302
    [No Abstract]   [Full Text] [Related]  

  • 59. [Chorionic gonadotropin excretion in threatened abortion, incomplete abortion and ectopic pregnancy].
    Hepp H
    Geburtshilfe Frauenheilkd; 1967 Oct; 27(10):990-9. PubMed ID: 5598836
    [No Abstract]   [Full Text] [Related]  

  • 60. Patterns of hormone excretion in abnormal pregnancy.
    Ginsburg J; Bell ET; Loraine JA
    Am J Obstet Gynecol; 1970 Aug; 107(8):1205-16. PubMed ID: 5458577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.